The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

August 2, 2020

Study Completion Date

January 10, 2021

Conditions
Fissure in AnoDiarrhea
Interventions
DRUG

Asacol is used to treat and prevent mild to moderate acute fissure disease

Comparison of two groups after 2 weeks in fissure wound healing, pain relief, pruritus, burning, bleeding, incontinence. Preliminary results of the study show the rate of fissure improvement 6 weeks after treatment, which is observed by clinical examination. Restoration is defined by complete epithelialization of the fissure site without scarring or residual cracks, and the secondary results will be a reduction in the amount of pain and other symptoms.

Trial Locations (1)

7193635899

Leila Ghahramani, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT05091775 - The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure | Biotech Hunter | Biotech Hunter